Brief Review of Newer Antiglycemic Agents as Options in the Treatment of Diabetic Kidney Disease
<p>Diabetes remains the leading cause of chronic kidney disease and with its increased prevalence the risk for Diabetic Kidney Disease (DKD) continues to rise and has a significant impact on diabetes morbidity and mortality as well as health care resources. There is a clear need to clinicians...
Saved in:
Main Authors: | Brian K Irons (Author), Molly Minze (Author), Lisa Chastain (Author), Michael E McMurry (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Obesity, Diabetes and Metabolic Syndrome - Peertechz Publications,
2020-05-11.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
by: Minze MG, et al.
Published: (2016) -
Newer management options in leprosy
by: P Narasimha Rao, et al.
Published: (2013) -
Newer Chemortherapeutic Agents In Leprosy
by: Ganapati R, et al.
Published: (1996) -
Bowen’s disease – a review of newer treatment options
by: Thorsten Neubert, et al.
Published: (2008) -
Newer Hemostatic Agents Used in the Practice of Dermatologic Surgery
by: Jill Henley, et al.
Published: (2013)